Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
Top Non Bank Lenders in Australia
-
DEEPX Expands First-Generation AI Chips into Intelligent Security and Video Analytics Markets
-
YS Biopharma Announces Unaudited Financial Results for the First Nine Months of Fiscal Year 2024
-
Main Street Announces Follow-On Investments
-
Vortex Metal Announces Upsized $1.75 Million Non Brokered Private Placement
-
Edison Awards Celebrate 2024 Innovation Winners at Annual Gala
-
Produced by the Jewish Community of Oporto, the "1506 - The Lisbon Genocide" documentary film shows a massacre of Jews that has been forgotten
-
Senstar Technologies Corporation Reports Fourth Quarter and Full Year 2023 Financial Results
-
AMCON Distributing Company Acquires Richmond Master Distributors, Inc.
-
GenFleet Therapeutics Announces FDA's Clinical Trial Approval for GFH925 (KRAS G12C Inhibitor) Monotherapy in Phase III Registrational Study Treating Metastatic Colorectal Cancer
-
Executive War College to Address, Clinical Laboratories’ and Genetic Testing Firms’ Perfect Storm, involving FDA’s Proposed LDT Rule, Payers Requiring Z-Codes on Genetic Test Claims, and Revisio
-
American Express First-Quarter Revenue Increased 11% to $15.8 Billion and EPS Increased 39% to $3.33, Reflecting Continued Business Momentum
-
Gateway Science Academy Selects Varsity Tutors for Schools to Provide Students with Additional Learning Resources
-
SES AI Teams Up with Worcester Polytechnic Institute on Lithium Metal Recycling Technology Research Initiative
-
GLOBE LIFE INC. ANNOUNCES FIRST QUARTER 2024 EARNINGS RELEASE AND CONFERENCE CALL
-
ACCO Brands Corporation Announces First Quarter 2024 Earnings Webcast
-
WestRock to Release Fiscal Second Quarter 2024 Results on May 2, 2024
-
Surmodics to Report Second Quarter of Fiscal 2024 Financial Results on May 1
-
Merlin Chain Launches MERL: A Major Leap Forward in Bitcoin Layer 2 Solutions
-
Tiziana Life Sciences Announces Study Results from Intranasal Anti-CD3 Foralumab in Multiple Sclerosis Patients with PIRA Highlighted in Neurology Today®
-
Merlin Chain Launches MERL: A Major Leap Forward in Bitcoin Layer 2 Solutions
-
Hofseth Biocare ASA: NOTICE OF ANNUAL GENERAL MEETING 2024
-
ProQR Achieves Successful Defense of New Challenge to its Axiomer™ IP Portfolio
-
Balchem Corporation Announces Quarterly Conference Call for First Quarter Financial Results on May 3, 2024
-
P&G Announces Fiscal Year 2024 Third Quarter Results
-
Bright Scholar Announces Unaudited Financial Results for the Second Quarter of Fiscal 2024
-
SLB Announces First-Quarter 2024 Results, Targeting to Return $7 Billion to Shareholders Over 2024–2025
-
ZTO Files Annual Report on Form 20-F for Fiscal Year 2023
-
Booming the Business in HoReCa: HOTELEX 2024 Concludes with Resounding Success.
-
Spearheading the New Era of Water Purification: ANGEL Space Master Series New Product Launch Event Held Successfully
-
TELUS International will release first quarter 2024 results and host an investor call on May 9
-
Giambattista Valli dazzles Barcelona during the Bridal Night
-
Dimensional Fund Advisors Ltd. : Form 8.3 - INTERNATIONAL PAPER CO - Ordinary Shares
-
Voya Increases Distribution Rate on 5 Funds
-
Baozun Strengthens Leadership Team
-
WOO X Research revises BTC price prediction and Q2 industry outlook, one day before BTC Halving
-
Huntington Bancshares Incorporated Reports 2024 First-Quarter Earnings
-
PermRock Royalty Trust Declares Monthly Cash Distribution
-
Fifth Third Bancorp Reports First Quarter 2024 Diluted Earnings Per Share of $0.70
-
Flash News: OKX Lists Merlin Chain's MERL Token on its Perpetual Futures Market, Expanding Trading Options
-
Ault Alliance Has Received an Investment of $44 Million to Date from Ault & Company under the November 2023 Securities Purchase Agreement
-
IEE Exhibiting Lineup of Avionics Display Products at Quad A Summit 2024
-
Baozun Files Annual Reports for Fiscal Year 2023
-
MMA INNOVATE 2024: THE MOST ANTICIPATED MARTECH EXHIBITION AND CONFERENCE HAS RETURNED
-
Dimensional Fund Advisors Ltd. : Form 8.3 - MONDI PLC - Ordinary Shares
-
Environmentally Friendly Poly Mailers From Elements Supply at Wholesale Prices
-
Alvotech signs U.S. agreement to expand access for newly approved high-concentration interchangeable biosimilar to Humira® (adalimumab)
-
Dimensional Fund Advisors Ltd. : Form 8.3 - DS SMITH PLC - Ordinary Shares
-
Alvotech signs U.S. agreement to expand access for newly approved high-concentration interchangeable biosimilar to Humira® (adalimumab)
-
Arcee.ai advances model merging innovations with launch of MergeKit hackathon

